EDIT-B®
Blood test to differentiate unipolar depression from bipolar disorder
EDITOX®
Cell-based solutions to mimic drug impact on RNA editing
EDITECH®
Integrated platform from RNA / DNA sequencing to machine learning and AI
Meet us
Precision Medicine World Conference – PMWC 2025
February 5 to 7 in Santa Clara, USA – in the heart of Silicon Valley
Come and meet us at the PMWC Precision Medicine Conference!
Our Deputy CEO and CSO Dinah Weissmann will present a talk titled: ” 𝗥𝗡𝗔 𝗲𝗱𝗶𝘁𝗶𝗻𝗴 𝗯𝗹𝗼𝗼𝗱 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀 𝗳𝗼𝗿 𝗯𝗶𝗽𝗼𝗹𝗮𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀” as part of Track S2, on February 6 11:00 – 11:15 A.M. PST.
You can also find our team at booth A214 (Hall A) throughout the conference!
Innovative Diagnostic Company
ALCEDIAG is an innovative diagnostic company specializing in the development and commercialization of blood tests, monitoring solutions, and companion diagnostics, primarily for mental health. These offerings are based upon the company’s distinctive expertise in epigenetics, RNA, and Artificial Intelligence, complemented by neurosciences and psychiatry.
ALCEDIAG’s unique approach is protected by seven patent families and supported by a global network of Key Opinion Leaders, who serve both as advocate for and early adopt of ALCEDIAG’s solutions.